Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxymetazoline gel for fecal incontinence in spinal cord injury
NCT02299557Phase 2Completed
- Sponsor
- RDD Pharma
- Start
- Nov 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Mucinex Full Force Nasal Spray in fecal incontinence (FI), sponsored by RDD Pharma. Started Nov 2014; status: completed.
02
Drugs
Mucinex Full Force Nasal Spray
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on NCT02299557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02299557.